Clinical trial
Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women
NCT00334152 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00334152 |
|---|---|
| Title | Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women |
| Official title | A Phase III Multicenter, Randomized, Double-blind, Parallel Group Study to Evaluate the Safety and Efficacy of the 30 mg Intravenous Formulation of the Neurokinin-1 Receptor Antagonist GW679769 for Prevention of Postoperative Nausea and Vomiting in Female Subjects at High Risk for Emesis |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Nausea and Vomiting, Postoperative, Postoperative Nausea and Vomiting |
| Intervention type | Drug |
| Interventions | casopitant |
| Enrollment | 515 |
| Start date | Mar 1, 2006 |
| Primary completion | Jul 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | Jun 6, 2006 |
| Last update posted | Mar 23, 2017 |
| Countries | Belgium, Canada, Czechia, Germany, Hong Kong, Pakistan, Philippines, Russia, Spain, Thailand, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: